Navigation Links
Hisamitsu Pharmaceutical Co., Inc. Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals, Inc.
Date:7/23/2009

The Depositary for the tender offer is American Stock Transfer and Trust Company, 59 Maiden Lane, Plaza Level, New York, NY 10038. The Information Agent for the tender offer is Georgeson Inc., 199 Water Street, 26th Floor, New York, NY 10038.

About Hisamitsu

Hisamitsu Pharmaceutical Co., Inc. is a leading pharmaceutical company that develops and markets prescription and over-the-counter ("OTC") pharmaceutical products using transdermal delivery systems technology. Its leading product in prescription pharmaceuticals is Mohrus((R)) series, ketoprofen patch for pain, and its leading brand in the OTC business is "Salonpas((R))". The company was founded in 1847 and is located in Saga, Japan. Additional information is available through its corporate website, http://www.hisamitsu.co.jp.

Additional Information

This press release is neither an offer to purchase nor a solicitation of an offer to sell shares of Noven. Hisamitsu has filed a tender offer statement with the SEC, and will mail an offer to purchase, forms of letter of transmittal and related documents to Noven shareholders. Noven has filed with the SEC, and will mail to Noven shareholders, a solicitation/recommendation statement on Schedule 14D-9. These documents contain important information about the tender offer and shareholders of Noven are urged to read them carefully when they become available.

These documents will be available at no charge at the SEC's website at www.sec.gov. The tender offer statement and the related materials may be obtained for free by directing a request by mail to Georgeson Inc., 199 Water Street, 26th Floor, New York, New York 10038 or by calling toll-free 888-897-6012.


'/>"/>
SOURCE Hisamitsu Pharmaceutical Co., Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , ... July 01, 2015 , ... ... said lead author Lisa Stolzenberg, a Professor in FIU’s School of International and ... 12 to 17 years who participated in the National Survey on Drug Use ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... contributing to newly released white paper: “Pro-actively Identifying the High-Cost Patient Population: Insights ... 1st and is available at: http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task ...
(Date:7/1/2015)... TEXAS (PRWEB) , ... July 01, 2015 , ... ... and solution provider of IBM software products, announced today that it has received ... for the integration, display and detailed analysis of data from multiple sources providing ...
(Date:7/1/2015)... FL (PRWEB) , ... July 01, 2015 , ... ... of premium delicatessen products, is helping families get ready for Independence Day celebrations ... sweet sliders, these easy and versatile options are perfect for any summertime get ...
(Date:7/1/2015)... ... July 01, 2015 , ... Bunion Bootie, ... Customers purchasing two or more Bunion Booties directly from their website, ... Bootie temporarily corrects misaligned toes and its ultra thin properties allow for protection ...
Breaking Medicine News(10 mins):Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2
... , , , , ... North Highland announced today the opening of its first Asia ... expansion strategy both in the United States and abroad. The new office will ... in the region, including some of the world,s largest organizations. , ...
... elderly may be controversial but wise, experts say , TUESDAY, ... flu may be wasted on the elderly and should be ... of the effect of antiviral treatment on the spread of ... behaves like the 1918 flu, antiviral drugs would not significantly ...
... Inverness Medical Innovations, Inc. (NYSE: IMA ), ... health at home through the merger of rapid diagnostics and health ... 30, 2009. , , In the second quarter ... to net revenue of $401.1 million in the second quarter of ...
... MAITLAND, Fla. , July 28 The STAR Cranial ... plagiocephaly and other head shape abnormalities, opened a third location on ... has offices in the Baltimore and Dallas areas, and has treated ... to as a cranial helmets or headbands. , , ...
... LOS ANGELES, July 28 Interested in a sperm ... California Cryobank (CCB) , the nation,s leading sperm bank, now ... allows clients to view online photos of celebrities who resemble each ... one client question we get is ,Who does this donor look ...
... Treat Diseases, Inc. (HTDS:PK) http://www.htdsmedical.com , Slavica Bio Chem ... the work of the medical team in the area of ... Europe only, several years ago. , Dr. Sanja Pekovic, Chief ... Serbian government TV did a feature about our work, and ...
Cached Medicine News:Health News:North Highland Opens First Asia Office in Shanghai 2Health News:Save Swine Flu Drugs for Younger Patients, Study Urges 2Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 2Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 3Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 4Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 5Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 6Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 7Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 8Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 9Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 10Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 11Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 12Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 13Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 14Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 15Health News:Inverness Medical Innovations Announces Second Quarter 2009 Results 16Health News:New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants 2Health News:New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants 3Health News:New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants 4Health News:New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants 5Health News:California Cryobank Introduces Celebrity Look-a-Likes for Sperm Donors 2Health News:Hard to Treat Diseases (HTDS) To Re Release European TV Segment In N. America For Potential Treatment Of MS 2Health News:Hard to Treat Diseases (HTDS) To Re Release European TV Segment In N. America For Potential Treatment Of MS 3Health News:Hard to Treat Diseases (HTDS) To Re Release European TV Segment In N. America For Potential Treatment Of MS 4
(Date:6/30/2015)... 2015 Velos, Inc., the pioneering software company ... and add customers who receive Clinical and Translational Science ... awarded by the National Institutes of Health currently use ... among the largest such market shares in its product ... community keeps growing as a result of our continued ...
(Date:6/30/2015)... N.J. , June 30, 2015  IGI Laboratories, ... based specialty generic pharmaceutical company, today announced ... (ANDA) to the U.S. Food and Drug Administration (FDA) ... ANDA submissions now pending at the FDA to twenty-seven. ... of the Company, commented, "We believe our current pipeline ...
(Date:6/30/2015)... June 30, 2015 Zynerba Pharmaceuticals, Inc. today announced ... with the U.S. Securities and Exchange Commission (SEC) relating to ... number of shares to be offered and the price range ... Jefferies LLC and Piper Jaffray & Co. will ... Genuity Inc. and Oppenheimer & Co. Inc. will act as ...
Breaking Medicine Technology:Velos continues adding CTSA customers - 40% now use Velos products 2IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015 2Zynerba Files Registration Statement for Proposed Initial Public Offering of Common Stock 2
... Ansell Limited (ANN.AX), a global leader in ... share of Yulex Corporation, a manufacturer of biopolymers derived ... any material impact on Ansell,s earnings per share in ... and Yulex executed an exclusive agreement for the global ...
... CHICAGO, Nov. 27, 2011   Montage Healthcare Solutions ... has been implemented and is in productive use at ... USC , Children,s National Medical Center and ... educators and other clinicians to search their own radiology ...
Cached Medicine Technology:Ansell Limited Acquires a Minority Share in Yulex Corporation 2Montage Announces Three More Hospitals Implement Their On-Demand Search and Data Mining Technology for Radiology Studies 2Montage Announces Three More Hospitals Implement Their On-Demand Search and Data Mining Technology for Radiology Studies 3
...
... QUANTA LiteTM ANA is an enzyme-linked ... of anti-nuclear antibodies (ANA) in human serum. ... in conjunction with clinical findings and other ... of rheumatic diseases such as systemic lupus ...
... Immuno Concepts manufactures slides that are ... technologist to decrease the number of pipetting ... patient sample dilutions on the slides. Ask ... procedure and these slides. These slide formats ...
... The ANA and ENA assays can ... negative for antinuclear antibodies, which are ... such as Systemic lupus erythematosus (Lupus), ... progressive systemic sclerosis, scleroderma, polymyositis, dermatomyositis, ...
Medicine Products: